Recent development of nuclear molecular imaging in thyroid cancer

H Liu, X Wang, R Yang, W Zeng, D Peng… - BioMed research …, 2018 - Wiley Online Library
Therapies targeting specific tumor pathways are easy to enter the clinic. To monitor
molecular changes, cellular processes, and tumor microenvironment, molecular imaging is …

Molecular imaging and theragnostics of thyroid cancers

L Giovanella, D Deandreis, A Vrachimis, A Campenni… - Cancers, 2022 - mdpi.com
Simple Summary According to the American Cancer Society, approximately 53,000 new
cases of thyroid cancer were diagnosed and more than 2200 people died from the disease …

[HTML][HTML] Nuclear molecular and theranostic imaging for differentiated thyroid cancer

A Sheikh, B Polack, Y Rodriguez… - Molecular imaging and …, 2017 - ncbi.nlm.nih.gov
Traditional nuclear medicine is rapidly being transformed by the evolving concepts in
molecular imaging and theranostics. The utility of new approaches in differentiated thyroid …

Updated review of nuclear molecular imaging of thyroid cancers

H Fu, R Sa, L Cheng, Y Jin, X Qiu, M Liu, L Chen - Endocrine Practice, 2021 - Elsevier
Objectives We initiate this comprehensive review to update the advances in this field by
objectively elucidating the efficacies of promising radiopharmaceuticals. Methods We …

Personalized medicine based on theranostic radioiodine molecular imaging for differentiated thyroid cancer

BC Ahn - BioMed research international, 2016 - Wiley Online Library
Molecular imaging based personalized therapy has been a fascinating concept for
individualized therapeutic strategy, which is able to attain the highest efficacy and reduce …

Next-generation molecular imaging of thyroid cancer

Y Jin, B Liu, MH Younis, G Huang, J Liu, W Cai, W Wei - Cancers, 2021 - mdpi.com
Simple Summary Molecular imaging utilizes radionuclides or artificially modified molecules
to image particular targets or pathways which are important in the pathogenesis of a certain …

An update on molecular biology of thyroid cancers

O Omur, Y Baran - Critical reviews in oncology/hematology, 2014 - Elsevier
Differentiated thyroid cancer (DTC) is the most common endocrinological malignancy. There
are several histological variants such as papillary and follicular thyroid carcinoma. Many …

Towards an era of precise diagnosis and treatment: Role of novel molecular modification-based imaging and therapy for dedifferentiated thyroid cancer

J Li, Y Zhang, F Sun, L Xing, X Sun - Frontiers in Endocrinology, 2022 - frontiersin.org
Dedifferentiated thyroid cancer is the major cause of mortality in thyroid cancer and is
difficult to treat. Hence, the essential molecular mechanisms involved in dedifferentiation …

Nuclear medicine in the era of precision medicine

BC Ahn - Nuclear Medicine and Molecular Imaging, 2017 - Springer
Genetic information on human diseases is being rapidly gathered with improvements in
biotechnology and is being used to stratify patients according to their likely response to a …

Molecular nuclear therapies for thyroid carcinoma

FA Verburg, B Brans, FM Mottaghy - Methods, 2011 - Elsevier
Thyroid cancer, divided in the subvarieties of papillary and follicular carcinoma, together
also called differentiated thyroid carcinoma (DTC), medullary thyroid carcinoma (MTC) and …